Daub H - Search Results

1

An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.

Godl K, Wissing J, Kurtenbach A, Habenberger P, Blencke S, Gutbrod H, Salassidis K, Stein-Gerlach M, Missio A, Cotten M, Daub H. Godl K, et al. Among authors: daub h. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15434-9. doi: 10.1073/pnas.2535024100. Epub 2003 Dec 10. Proc Natl Acad Sci U S A. 2003. PMID: 14668439 Free PMC article.

2

Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein.

Daub H, Blencke S, Habenberger P, Kurtenbach A, Dennenmoser J, Wissing J, Ullrich A, Cotten M. Daub H, et al. J Virol. 2002 Aug;76(16):8124-37. doi: 10.1128/jvi.76.16.8124-8137.2002. J Virol. 2002. PMID: 12134018 Free PMC article.

3

Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors.

Blencke S, Ullrich A, Daub H. Blencke S, et al. Among authors: daub h. J Biol Chem. 2003 Apr 25;278(17):15435-40. doi: 10.1074/jbc.M211158200. Epub 2003 Feb 19. J Biol Chem. 2003. PMID: 12594213 Free article.

4

Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein.

Zech B, Kurtenbach A, Krieger N, Strand D, Blencke S, Morbitzer M, Salassidis K, Cotten M, Wissing J, Obert S, Bartenschlager R, Herget T, Daub H. Zech B, et al. Among authors: daub h. J Gen Virol. 2003 Mar;84(Pt 3):555-560. doi: 10.1099/vir.0.18801-0. J Gen Virol. 2003. PMID: 12604805

5

Exploiting features of adenovirus replication to support mammalian kinase production.

Cotten M, Stegmueller K, Eickhoff J, Hanke M, Herzberger K, Herget T, Choidas A, Daub H, Godl K. Cotten M, et al. Among authors: daub h. Nucleic Acids Res. 2003 Nov 1;31(21):e128. doi: 10.1093/nar/gng128. Nucleic Acids Res. 2003. PMID: 14576328 Free PMC article.

6

Proteomic analysis of kinase inhibitor selectivity and function.

Godl K, Daub H. Godl K, et al. Among authors: daub h. Cell Cycle. 2004 Apr;3(4):393-5. Epub 2004 Apr 1. Cell Cycle. 2004. PMID: 14752275

7

Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors.

Brehmer D, Godl K, Zech B, Wissing J, Daub H. Brehmer D, et al. Among authors: daub h. Mol Cell Proteomics. 2004 May;3(5):490-500. doi: 10.1074/mcp.M300139-MCP200. Epub 2004 Feb 9. Mol Cell Proteomics. 2004. PMID: 14769951 Free article.

8

Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors.

Blencke S, Zech B, Engkvist O, Greff Z, Orfi L, Horváth Z, Kéri G, Ullrich A, Daub H. Blencke S, et al. Among authors: daub h. Chem Biol. 2004 May;11(5):691-701. doi: 10.1016/j.chembiol.2004.02.029. Chem Biol. 2004. PMID: 15157880

9

Evaluation of kinase inhibitor selectivity by chemical proteomics.

Daub H, Godl K, Brehmer D, Klebl B, Müller G. Daub H, et al. Assay Drug Dev Technol. 2004 Apr;2(2):215-24. doi: 10.1089/154065804323056558. Assay Drug Dev Technol. 2004. PMID: 15165517 Review.

10

Chemical proteomic analysis reveals alternative modes of action for pyrido[2,3-d]pyrimidine kinase inhibitors.

Wissing J, Godl K, Brehmer D, Blencke S, Weber M, Habenberger P, Stein-Gerlach M, Missio A, Cotten M, Müller S, Daub H. Wissing J, et al. Among authors: daub h. Mol Cell Proteomics. 2004 Dec;3(12):1181-93. doi: 10.1074/mcp.M400124-MCP200. Epub 2004 Oct 8. Mol Cell Proteomics. 2004. PMID: 15475568 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters